In the current case series, daptomycin was shown to be a safe and effective therapeutic option in the management of VRE UTIs. Because of the increasing prevalence of VRE infection and the limited ...

Background: This subgroup analysis of the European Cubicin Outcomes Registry Experience evaluated the safety and effectiveness of daptomycin in children and adolescent patients (<18 years).

The risk for treatment failure and hospital readmission was lower among patients with MSSI BSIs who received high- vs standard-dose daptomycin as OPAT after discharge.

One of these, daptomycin, also belongs to the lipopeptide class of antibiotics. In a paper published in Microbiology Spectrum recently, Dr Tanya Decker (neé Clements) from Stellenbosch University ...